Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| AVANIR PHARMACEUTICALS | 65 690 | déclaré | 09 sept. 2011 | tx 47+1 361 286−374 652 |
| Axsome Therapeutics, Inc. | 6 022 | déclaré | 23 déc. 2015 | tx 3+11 044 |
| Longboard Pharmaceuticals, Inc. | 0 | déclaré | 02 déc. 2024 | tx 28+568 434−568 434 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 02 déc. 2024 | TENDER | Longboard Pharmaceuticals, Inc. | 30 554 | 60.00 USD | |
| 02 déc. 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 107 560 | — | deriv |
| 02 déc. 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 96 300 | — | deriv |
| 02 déc. 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 175 946 | — | deriv |
| 02 déc. 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 17 920 | — | deriv |
| 02 déc. 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 9 500 | — | deriv |
| 19 nov. 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 30 554 | 6.00 USD | |
| 19 nov. 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 30 554 | 0.00 USD | deriv |
| 25 oct. 2024 | GRANT_AWARD | Longboard Pharmaceuticals, Inc. | 9 500 | 0.00 USD | deriv |
| 15 oct. 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16 667 | 4.35 USD | |
| 15 oct. 2024 | SALE | Longboard Pharmaceuticals, Inc. | 16 667 | 59.04 USD | |
| 15 oct. 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16 667 | 0.00 USD | deriv |
| 16 sept. 2024 | SALE | Longboard Pharmaceuticals, Inc. | 1 200 | 33.12 USD | |
| 16 sept. 2024 | SALE | Longboard Pharmaceuticals, Inc. | 1 900 | 34.04 USD | |
| 16 sept. 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16 666 | 4.35 USD | |
| 16 sept. 2024 | SALE | Longboard Pharmaceuticals, Inc. | 9 366 | 30.89 USD | |
| 16 sept. 2024 | SALE | Longboard Pharmaceuticals, Inc. | 4 200 | 31.81 USD | |
| 16 sept. 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16 666 | 0.00 USD | deriv |
| 12 août 2024 | SALE | Longboard Pharmaceuticals, Inc. | 6 191 | 35.03 USD | |
| 25 juin 2024 | SALE | Longboard Pharmaceuticals, Inc. | 100 | 20.87 USD | |
| 12 août 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16 667 | 4.35 USD | |
| 12 août 2024 | SALE | Longboard Pharmaceuticals, Inc. | 10 476 | 34.55 USD | |
| 23 janv. 2024 | PURCHASE | Longboard Pharmaceuticals, Inc. | 100 | 24.82 USD | 1er après silence |
| 12 août 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16 667 | 0.00 USD | deriv |
| 08 févr. 2024 | GRANT_AWARD | Longboard Pharmaceuticals, Inc. | 17 920 | 0.00 USD |
3 achats déclarés après au moins 12 mois de silence — dernière occurrence le 23 janv. 2024.